Colonoscopic Fecal Bacteriotherapy in the Treatment of Recurrent Clostridium Difficile Infection - Results and Follow-up: 367
The DOI matches its Crossref record.
Abstract
Purpose: In recent years, there has been a dramatic increase in frequency and severity of Clostridium Difficile infection (CDI), as well as recurrent CDI (RCDI). Approximately 20% of patients that experience CDI will have a recurrence; of those, 50% will have multiple recurrences with resultant debility and, sometimes, death. Fecal bacteriotherapy (or fecal transplantation) administered via either nasogastric tube, rectal enema or colonscopically, has been reported to be successful in over 100 patients with RCDI. Methods: We report our experience with our 1st 13 patients treated with fecal bacteriotherapy at our institution between July 2009 and April 2010. 12 had RCDI and 1 refractory CDI. Unless deemed terminally ill, no patients were excluded from treatment because of co-morbidities. 12 of 13 patients were ill enough to have been hospitalized or homebound at the time of fecal bacteriotherapy. “Donors” underwent serologic (Hepatitis A,B,C; STS, HIV 1&2) and stool evaluation (CDT; culture for enteric pathogens; O&P). So that their pre-treatment status was known, patients also underwent serologic testing for Hepatitis A,B,C; STS and HIV 1&2. Donor exclusions: antibiotic use in prior 8 weeks; recent diarrhea or chronic diarrhea; immunologic disorder or use of immunosuppressant medications. Donor stool was collected on the morning of the patient's colonoscopy, liquefied with non-bacteriostatic saline to a thick liquid consistency that allowed aspiration into 60 ml syringes. Between 300 and 500ml were infused via biopsy channel of the colonoscope; approximetly 50% was placed in cecum-right colon; the remainder infused sequentially on withdrawal. Results: 13 patients (6 females, 7 males), aged 32-87 (mean 67) were treated. Patients with RCDI had experienced a mean of 4 prior episodes of CDI (range 3-7), over a mean of 11.5 months (range 3-24). To date, patients have been followed up for mean of 5 months (range 1-10). 12 of 13 experienced resolution of diarrhea; in 1, diarrhea persisted with stool CDT (+). Stool for CDT was negative in 10 of 10 patients tested ≥ 30 days post treatment. 3 patients have died (B strep pneumonia 1 month after FB; superior mesenteric vein thrombosis in patient with Crohn's disease 5 months after FB; ovarian cancer 7 months after FB). The patient with refractory CDI underwent subsequent successful liver transplantation. One patient relapsed at 7 months after FB. 2 patients required antibiotics during follow up, without diarrhea recurring. Conclusion: Colonoscopic Fecal Bacteriotherapy is effective in the treatment of recurrent and refractory CDI, even in patients with severe co-morbidities, with a success rate of 92% (12 of 13).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ursell, L. K., Metcalf, J. L., Parfrey, L. W., & Knight, R. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00493.x · Cited by 1,255
Debast, S. B., Bauer, M. P., & Kuijper, E. J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12418 · Cited by 1,215
Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.59 · Cited by 904
Fecal microbiota transplantation and emerging applications
Borody, T. J., & Khoruts, A. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.244 · Cited by 677
Systematic Review: Adverse Events of Fecal Microbiota Transplantation
Wang, S., Xu, M., Wang, W., Cao, X., Piao, M., Khan, S., Yan, F., Cao, H., & Wang, B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161174 · Cited by 409
Metadata
- Authors
- Mellow, M., & Kanatzar, A.
- Venue
- American Journal of Gastroenterology
- Published
- 2010-10
- Volume
- 105
- Pages
- S135
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2921817069
- Cited by
- 19
- References
- 0
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Colonoscopic Fecal Bacteriotherapy in the Treatment of Recurrent Clostridium Difficile Infection - Results and Follow-up: 367. https://app.cochat.ai/papers/10.14309/00000434-201010001-00367
- The paper
- Mellow, M., & Kanatzar, A. (2010). Colonoscopic Fecal Bacteriotherapy in the Treatment of Recurrent Clostridium Difficile Infection - Results and Follow-up: 367. American Journal of Gastroenterology. https://doi.org/10.14309/00000434-201010001-00367
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.